Global Incretin-Based Drugs Market Research Report 2017

インクレチン系薬剤の世界市場

◆タイトル:Global Incretin-Based Drugs Market Research Report 2017
◆商品コード:QYR70902731
◆調査・発行会社:QYResearch
◆発行日:2017年8月25日
◆ページ数:100
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD2,900 ⇒換算¥316,100見積依頼/購入/質問フォーム
Enterprise(全社内共有可)USD5,800 ⇒換算¥632,200見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

QYResearchが発行した当調査レポートでは、世界のインクレチン系薬剤市場について調査・分析し、インクレチン系薬剤の世界市場概観、インクレチン系薬剤の種類別市場分析、用途別市場分析、インクレチン系薬剤の世界市場規模予測、関連企業分析、主要地域別分析(北米市場、ヨーロッパ市場、中国市場、日本市場、アジア市場など)、関連企業情報、価格情報、販売動向、市場動向、貿易動向、市場環境分析情報などを含め、以下の構成でお届けいたします。

・インクレチン系薬剤の世界市場概観
・インクレチン系薬剤の種類別市場規模
・インクレチン系薬剤の用途別市場規模
・インクレチン系薬剤の世界市場規模
・インクレチン系薬剤の世界市場規模予測
・インクレチン系薬剤の主要地域別市場規模
・インクレチン系薬剤の北米市場規模・予測
・インクレチン系薬剤のヨーロッパ市場規模・予測
・インクレチン系薬剤の中国市場規模・予測
・インクレチン系薬剤の日本市場規模・予測
・インクレチン系薬剤のアジア市場規模・予測
・インクレチン系薬剤の製造メーカー分析
・インクレチン系薬剤のメーカー別生産量
・インクレチン系薬剤のメーカー別市場シェア
・インクレチン系薬剤の価格動向・価格分析
・インクレチン系薬剤の販売(売上高)動向
・インクレチン系薬剤の貿易(輸出・輸入)動向
・インクレチン系薬剤の産業チェーン分析
・インクレチン系薬剤のマーケティング戦略分析
・インクレチン系薬剤の販売業者(代理店)リスト
・インクレチン系薬剤の市場環境分析
...

In this report, the global Incretin-Based Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Incretin-Based Drugs in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
Global Incretin-Based Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
AstraZeneca plc
Boehringer Ingelheim GmbH
GlaxoSmithKline Plc
Johnson & Johnson
Merck & Co., Inc.
Takeda Pharmaceutical Company Ltd
Sanofi S.A.
Novartis AG
Eli Lilly and Company
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
By Formulation
Injectable
Oral
By Drug
Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
Glucagon-Like Peptide-1 Receptor (GLP-1) Agonists
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Incretin-Based Drugs for each application, including
Hospitals
Pharmacies
Diagnostic Centers
Other

If you have any special requirements, please let us know and we will offer you the report as you want.

【レポートの目次】

Table of Contents

Global Incretin-Based Drugs Market Research Report 2017
1 Incretin-Based Drugs Market Overview
1.1 Product Overview and Scope of Incretin-Based Drugs
1.2 Incretin-Based Drugs Segment By Formulation
1.2.1 Global Incretin-Based Drugs Production and CAGR (%) Comparison By Formulation (Product Category)(2012-2022)
1.2.2 Global Incretin-Based Drugs Production Market Share By Formulation (Product Category) in 2016
1.2.3 Injectable
1.2.4 Oral
1.3 Incretin-Based Drugs Segment By Drug
1.3.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
1.3.2 Glucagon-Like Peptide-1 Receptor (GLP-1) Agonists
1.4 Global Incretin-Based Drugs Segment by Application
1.4.1 Incretin-Based Drugs Consumption (Sales) Comparison by Application (2012-2022)
1.4.2 Hospitals
1.4.3 Pharmacies
1.4.4 Diagnostic Centers
1.4.5 Other
1.5 Global Incretin-Based Drugs Market by Region (2012-2022)
1.5.1 Global Incretin-Based Drugs Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.5.2 North America Status and Prospect (2012-2022)
1.5.3 Europe Status and Prospect (2012-2022)
1.5.4 China Status and Prospect (2012-2022)
1.5.5 Japan Status and Prospect (2012-2022)
1.5.6 Southeast Asia Status and Prospect (2012-2022)
1.5.7 India Status and Prospect (2012-2022)
1.6 Global Market Size (Value) of Incretin-Based Drugs (2012-2022)
1.6.1 Global Incretin-Based Drugs Revenue Status and Outlook (2012-2022)
1.6.2 Global Incretin-Based Drugs Capacity, Production Status and Outlook (2012-2022)

2 Global Incretin-Based Drugs Market Competition by Manufacturers
2.1 Global Incretin-Based Drugs Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Incretin-Based Drugs Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Incretin-Based Drugs Production and Share by Manufacturers (2012-2017)
2.2 Global Incretin-Based Drugs Revenue and Share by Manufacturers (2012-2017)
2.3 Global Incretin-Based Drugs Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Incretin-Based Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Incretin-Based Drugs Market Competitive Situation and Trends
2.5.1 Incretin-Based Drugs Market Concentration Rate
2.5.2 Incretin-Based Drugs Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Incretin-Based Drugs Capacity, Production, Revenue (Value) by Region (2012-2017)
3.1 Global Incretin-Based Drugs Capacity and Market Share by Region (2012-2017)
3.2 Global Incretin-Based Drugs Production and Market Share by Region (2012-2017)
3.3 Global Incretin-Based Drugs Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Incretin-Based Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Incretin-Based Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Incretin-Based Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Incretin-Based Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Incretin-Based Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Incretin-Based Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Incretin-Based Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Incretin-Based Drugs Supply (Production), Consumption, Export, Import by Region (2012-2017)
4.1 Global Incretin-Based Drugs Consumption by Region (2012-2017)
4.2 North America Incretin-Based Drugs Production, Consumption, Export, Import (2012-2017)
4.3 Europe Incretin-Based Drugs Production, Consumption, Export, Import (2012-2017)
4.4 China Incretin-Based Drugs Production, Consumption, Export, Import (2012-2017)
4.5 Japan Incretin-Based Drugs Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Incretin-Based Drugs Production, Consumption, Export, Import (2012-2017)
4.7 India Incretin-Based Drugs Production, Consumption, Export, Import (2012-2017)

5 Global Incretin-Based Drugs Production, Revenue (Value), Price Trend by Type
5.1 Global Incretin-Based Drugs Production and Market Share by Type (2012-2017)
5.2 Global Incretin-Based Drugs Revenue and Market Share by Type (2012-2017)
5.3 Global Incretin-Based Drugs Price by Type (2012-2017)
5.4 Global Incretin-Based Drugs Production Growth by Type (2012-2017)

6 Global Incretin-Based Drugs Market Analysis by Application
6.1 Global Incretin-Based Drugs Consumption and Market Share by Application (2012-2017)
6.2 Global Incretin-Based Drugs Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Incretin-Based Drugs Manufacturers Profiles/Analysis
7.1 AstraZeneca plc
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Incretin-Based Drugs Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 AstraZeneca plc Incretin-Based Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 Boehringer Ingelheim GmbH
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Incretin-Based Drugs Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Boehringer Ingelheim GmbH Incretin-Based Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business/Business Overview
7.3 GlaxoSmithKline Plc
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Incretin-Based Drugs Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 GlaxoSmithKline Plc Incretin-Based Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Main Business/Business Overview
7.4 Johnson & Johnson
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Incretin-Based Drugs Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Johnson & Johnson Incretin-Based Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Main Business/Business Overview
7.5 Merck & Co., Inc.
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Incretin-Based Drugs Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Merck & Co., Inc. Incretin-Based Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Main Business/Business Overview
7.6 Takeda Pharmaceutical Company Ltd
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Incretin-Based Drugs Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Takeda Pharmaceutical Company Ltd Incretin-Based Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Main Business/Business Overview
7.7 Sanofi S.A.
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Incretin-Based Drugs Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Sanofi S.A. Incretin-Based Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Main Business/Business Overview
7.8 Novartis AG
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Incretin-Based Drugs Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Novartis AG Incretin-Based Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.8.4 Main Business/Business Overview
7.9 Eli Lilly and Company
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Incretin-Based Drugs Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Eli Lilly and Company Incretin-Based Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.9.4 Main Business/Business Overview

8 Incretin-Based Drugs Manufacturing Cost Analysis
8.1 Incretin-Based Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Incretin-Based Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Incretin-Based Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Incretin-Based Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Incretin-Based Drugs Market Forecast (2017-2022)
12.1 Global Incretin-Based Drugs Capacity, Production, Revenue Forecast (2017-2022)
12.1.1 Global Incretin-Based Drugs Capacity, Production and Growth Rate Forecast (2017-2022)
12.1.2 Global Incretin-Based Drugs Revenue and Growth Rate Forecast (2017-2022)
12.1.3 Global Incretin-Based Drugs Price and Trend Forecast (2017-2022)
12.2 Global Incretin-Based Drugs Production, Consumption , Import and Export Forecast by Region (2017-2022)
12.2.1 North America Incretin-Based Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.2 Europe Incretin-Based Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.3 China Incretin-Based Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.4 Japan Incretin-Based Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.5 Southeast Asia Incretin-Based Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.6 India Incretin-Based Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Incretin-Based Drugs Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Incretin-Based Drugs Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer

List of Tables and Figures

Figure Picture of Incretin-Based Drugs
Figure Global Incretin-Based Drugs Production (MT) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Incretin-Based Drugs Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Injectable
Table Major Manufacturers of Injectable
Figure Product Picture of Oral
Table Major Manufacturers of Oral
Figure Global Incretin-Based Drugs Consumption (MT) by Applications (2012-2022)
Figure Global Incretin-Based Drugs Consumption Market Share by Applications in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Pharmacies Examples
Table Key Downstream Customer in Pharmacies
Figure Diagnostic Centers Examples
Table Key Downstream Customer in Diagnostic Centers
Figure Other Examples
Table Key Downstream Customer in Other
Figure Global Incretin-Based Drugs Market Size (Million USD), Comparison (MT) and CAGR (%) by Regions (2012-2022)
Figure North America Incretin-Based Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Incretin-Based Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Incretin-Based Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Incretin-Based Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Incretin-Based Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Incretin-Based Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Incretin-Based Drugs Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Incretin-Based Drugs Capacity, Production (MT) Status and Outlook (2012-2022)
Figure Global Incretin-Based Drugs Major Players Product Capacity (MT) (2012-2017)
Table Global Incretin-Based Drugs Capacity (MT) of Key Manufacturers (2012-2017)
Table Global Incretin-Based Drugs Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Incretin-Based Drugs Capacity (MT) of Key Manufacturers in 2016
Figure Global Incretin-Based Drugs Capacity (MT) of Key Manufacturers in 2017
Figure Global Incretin-Based Drugs Major Players Product Production (MT) (2012-2017)
Table Global Incretin-Based Drugs Production (MT) of Key Manufacturers (2012-2017)
Table Global Incretin-Based Drugs Production Share by Manufacturers (2012-2017)
Figure 2016 Incretin-Based Drugs Production Share by Manufacturers
Figure 2017 Incretin-Based Drugs Production Share by Manufacturers
Figure Global Incretin-Based Drugs Major Players Product Revenue (Million USD) (2012-2017)
Table Global Incretin-Based Drugs Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Incretin-Based Drugs Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Incretin-Based Drugs Revenue Share by Manufacturers
Table 2017 Global Incretin-Based Drugs Revenue Share by Manufacturers
Table Global Market Incretin-Based Drugs Average Price (K USD/Kg) of Key Manufacturers (2012-2017)
Figure Global Market Incretin-Based Drugs Average Price (K USD/Kg) of Key Manufacturers in 2016
Table Manufacturers Incretin-Based Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Incretin-Based Drugs Product Category
Figure Incretin-Based Drugs Market Share of Top 3 Manufacturers
Figure Incretin-Based Drugs Market Share of Top 5 Manufacturers
Table Global Incretin-Based Drugs Capacity (MT) by Region (2012-2017)
Figure Global Incretin-Based Drugs Capacity Market Share by Region (2012-2017)
Figure Global Incretin-Based Drugs Capacity Market Share by Region (2012-2017)
Figure 2016 Global Incretin-Based Drugs Capacity Market Share by Region
Table Global Incretin-Based Drugs Production by Region (2012-2017)
Figure Global Incretin-Based Drugs Production (MT) by Region (2012-2017)
Figure Global Incretin-Based Drugs Production Market Share by Region (2012-2017)
Figure 2016 Global Incretin-Based Drugs Production Market Share by Region
Table Global Incretin-Based Drugs Revenue (Million USD) by Region (2012-2017)
Table Global Incretin-Based Drugs Revenue Market Share by Region (2012-2017)
Figure Global Incretin-Based Drugs Revenue Market Share by Region (2012-2017)
Table 2016 Global Incretin-Based Drugs Revenue Market Share by Region
Figure Global Incretin-Based Drugs Capacity, Production (MT) and Growth Rate (2012-2017)
Table Global Incretin-Based Drugs Capacity, Production (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Table North America Incretin-Based Drugs Capacity, Production (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Table Europe Incretin-Based Drugs Capacity, Production (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Table China Incretin-Based Drugs Capacity, Production (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Table Japan Incretin-Based Drugs Capacity, Production (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Table Southeast Asia Incretin-Based Drugs Capacity, Production (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Table India Incretin-Based Drugs Capacity, Production (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Table Global Incretin-Based Drugs Consumption (MT) Market by Region (2012-2017)
Table Global Incretin-Based Drugs Consumption Market Share by Region (2012-2017)
Figure Global Incretin-Based Drugs Consumption Market Share by Region (2012-2017)
Figure 2016 Global Incretin-Based Drugs Consumption (MT) Market Share by Region
Table North America Incretin-Based Drugs Production, Consumption, Import & Export (MT) (2012-2017)
Table Europe Incretin-Based Drugs Production, Consumption, Import & Export (MT) (2012-2017)
Table China Incretin-Based Drugs Production, Consumption, Import & Export (MT) (2012-2017)
Table Japan Incretin-Based Drugs Production, Consumption, Import & Export (MT) (2012-2017)
Table Southeast Asia Incretin-Based Drugs Production, Consumption, Import & Export (MT) (2012-2017)
Table India Incretin-Based Drugs Production, Consumption, Import & Export (MT) (2012-2017)
Table Global Incretin-Based Drugs Production (MT) by Type (2012-2017)
Table Global Incretin-Based Drugs Production Share by Type (2012-2017)
Figure Production Market Share of Incretin-Based Drugs by Type (2012-2017)
Figure 2016 Production Market Share of Incretin-Based Drugs by Type
Table Global Incretin-Based Drugs Revenue (Million USD) by Type (2012-2017)
Table Global Incretin-Based Drugs Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Incretin-Based Drugs by Type (2012-2017)
Figure 2016 Revenue Market Share of Incretin-Based Drugs by Type
Table Global Incretin-Based Drugs Price (K USD/Kg) by Type (2012-2017)
Figure Global Incretin-Based Drugs Production Growth by Type (2012-2017)
Table Global Incretin-Based Drugs Consumption (MT) by Application (2012-2017)
Table Global Incretin-Based Drugs Consumption Market Share by Application (2012-2017)
Figure Global Incretin-Based Drugs Consumption Market Share by Applications (2012-2017)
Figure Global Incretin-Based Drugs Consumption Market Share by Application in 2016
Table Global Incretin-Based Drugs Consumption Growth Rate by Application (2012-2017)
Figure Global Incretin-Based Drugs Consumption Growth Rate by Application (2012-2017)
Table AstraZeneca plc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca plc Incretin-Based Drugs Capacity, Production (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure AstraZeneca plc Incretin-Based Drugs Production Growth Rate (2012-2017)
Figure AstraZeneca plc Incretin-Based Drugs Production Market Share (2012-2017)
Figure AstraZeneca plc Incretin-Based Drugs Revenue Market Share (2012-2017)
Table Boehringer Ingelheim GmbH Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim GmbH Incretin-Based Drugs Capacity, Production (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim GmbH Incretin-Based Drugs Production Growth Rate (2012-2017)
Figure Boehringer Ingelheim GmbH Incretin-Based Drugs Production Market Share (2012-2017)
Figure Boehringer Ingelheim GmbH Incretin-Based Drugs Revenue Market Share (2012-2017)
Table GlaxoSmithKline Plc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Plc Incretin-Based Drugs Capacity, Production (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Plc Incretin-Based Drugs Production Growth Rate (2012-2017)
Figure GlaxoSmithKline Plc Incretin-Based Drugs Production Market Share (2012-2017)
Figure GlaxoSmithKline Plc Incretin-Based Drugs Revenue Market Share (2012-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Incretin-Based Drugs Capacity, Production (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Johnson & Johnson Incretin-Based Drugs Production Growth Rate (2012-2017)
Figure Johnson & Johnson Incretin-Based Drugs Production Market Share (2012-2017)
Figure Johnson & Johnson Incretin-Based Drugs Revenue Market Share (2012-2017)
Table Merck & Co., Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck & Co., Inc. Incretin-Based Drugs Capacity, Production (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Merck & Co., Inc. Incretin-Based Drugs Production Growth Rate (2012-2017)
Figure Merck & Co., Inc. Incretin-Based Drugs Production Market Share (2012-2017)
Figure Merck & Co., Inc. Incretin-Based Drugs Revenue Market Share (2012-2017)
Table Takeda Pharmaceutical Company Ltd Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Takeda Pharmaceutical Company Ltd Incretin-Based Drugs Capacity, Production (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Takeda Pharmaceutical Company Ltd Incretin-Based Drugs Production Growth Rate (2012-2017)
Figure Takeda Pharmaceutical Company Ltd Incretin-Based Drugs Production Market Share (2012-2017)
Figure Takeda Pharmaceutical Company Ltd Incretin-Based Drugs Revenue Market Share (2012-2017)
Table Sanofi S.A. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi S.A. Incretin-Based Drugs Capacity, Production (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Sanofi S.A. Incretin-Based Drugs Production Growth Rate (2012-2017)
Figure Sanofi S.A. Incretin-Based Drugs Production Market Share (2012-2017)
Figure Sanofi S.A. Incretin-Based Drugs Revenue Market Share (2012-2017)
Table Novartis AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis AG Incretin-Based Drugs Capacity, Production (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Novartis AG Incretin-Based Drugs Production Growth Rate (2012-2017)
Figure Novartis AG Incretin-Based Drugs Production Market Share (2012-2017)
Figure Novartis AG Incretin-Based Drugs Revenue Market Share (2012-2017)
Table Eli Lilly and Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly and Company Incretin-Based Drugs Capacity, Production (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Eli Lilly and Company Incretin-Based Drugs Production Growth Rate (2012-2017)
Figure Eli Lilly and Company Incretin-Based Drugs Production Market Share (2012-2017)
Figure Eli Lilly and Company Incretin-Based Drugs Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Incretin-Based Drugs
Figure Manufacturing Process Analysis of Incretin-Based Drugs
Figure Incretin-Based Drugs Industrial Chain Analysis
Table Raw Materials Sources of Incretin-Based Drugs Major Manufacturers in 2016
Table Major Buyers of Incretin-Based Drugs
Table Distributors/Traders List
Figure Global Incretin-Based Drugs Capacity, Production (MT) and Growth Rate Forecast (2017-2022)
Figure Global Incretin-Based Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Incretin-Based Drugs Price (Million USD) and Trend Forecast (2017-2022)
Table Global Incretin-Based Drugs Production (MT) Forecast by Region (2017-2022)
Figure Global Incretin-Based Drugs Production Market Share Forecast by Region (2017-2022)
Table Global Incretin-Based Drugs Consumption (MT) Forecast by Region (2017-2022)
Figure Global Incretin-Based Drugs Consumption Market Share Forecast by Region (2017-2022)
Figure North America Incretin-Based Drugs Production (MT) and Growth Rate Forecast (2017-2022)
Figure North America Incretin-Based Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Incretin-Based Drugs Production, Consumption, Export and Import (MT) Forecast (2017-2022)
Figure Europe Incretin-Based Drugs Production (MT) and Growth Rate Forecast (2017-2022)
Figure Europe Incretin-Based Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Incretin-Based Drugs Production, Consumption, Export and Import (MT) Forecast (2017-2022)
Figure China Incretin-Based Drugs Production (MT) and Growth Rate Forecast (2017-2022)
Figure China Incretin-Based Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Incretin-Based Drugs Production, Consumption, Export and Import (MT) Forecast (2017-2022)
Figure Japan Incretin-Based Drugs Production (MT) and Growth Rate Forecast (2017-2022)
Figure Japan Incretin-Based Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Incretin-Based Drugs Production, Consumption, Export and Import (MT) Forecast (2017-2022)
Figure Southeast Asia Incretin-Based Drugs Production (MT) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Incretin-Based Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Incretin-Based Drugs Production, Consumption, Export and Import (MT) Forecast (2017-2022)
Figure India Incretin-Based Drugs Production (MT) and Growth Rate Forecast (2017-2022)
Figure India Incretin-Based Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Incretin-Based Drugs Production, Consumption, Export and Import (MT) Forecast (2017-2022)
Table Global Incretin-Based Drugs Production (MT) Forecast by Type (2017-2022)
Figure Global Incretin-Based Drugs Production (MT) Forecast by Type (2017-2022)
Table Global Incretin-Based Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Incretin-Based Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Global Incretin-Based Drugs Price Forecast by Type (2017-2022)
Table Global Incretin-Based Drugs Consumption (MT) Forecast by Application (2017-2022)
Figure Global Incretin-Based Drugs Consumption (MT) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source



【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[インクレチン系薬剤の世界市場] (Global Incretin-Based Drugs Market Research Report 2017 / QYR70902731)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆